Mednax INC Com (MD) Market Value Rose While Ipg Investment Advisors LLC Raised Position by $8.48 Billion

May 24, 2018 - By Rodney Autry


Ipg Investment Advisors Llc increased its stake in Mednax Inc Com (MD) by 79.13% based on its latest 2017Q4 regulatory filing with the SEC. Ipg Investment Advisors Llc bought 158,680 shares as the company’s stock rose 2.30% while stock markets declined. The institutional investor held 359,200 shares of the health care company at the end of 2017Q4, valued at $19.20B, up from 200,520 at the end of the previous reported quarter. Ipg Investment Advisors Llc who had been investing in Mednax Inc Com for a number of months, seems to be bullish on the $4.38 billion market cap company. The stock increased 0.19% or $0.09 during the last trading session, reaching $46.87. About 236,900 shares traded. MEDNAX, Inc. (NYSE:MD) has declined 21.42% since May 24, 2017 and is downtrending. It has underperformed by 32.97% the S&P500.

Ipg Investment Advisors Llc, which manages about $978.63M and $240.36B US Long portfolio, decreased its stake in Select Sector Spdr Tr Financial (XLF) by 45,600 shares to 21,123 shares, valued at $589.54 million in 2017Q4, according to the filing. It also reduced its holding in Facebook Inc Cl A (NASDAQ:FB) by 1,719 shares in the quarter, leaving it with 63,689 shares, and cut its stake in Citigroup Inc Com New (NYSE:C).

MEDNAX, Inc. (NYSE:MD) Ratings Coverage

Among 11 analysts covering Mednax Inc (NYSE:MD), 4 have Buy rating, 0 Sell and 7 Hold. Therefore 36% are positive. Mednax Inc had 14 analyst reports since December 4, 2017 according to SRatingsIntel. On Thursday, February 8 the stock rating was maintained by Piper Jaffray with “Buy”. The rating was maintained by Stephens on Thursday, February 8 with “Buy”. SunTrust maintained the stock with “Hold” rating in Wednesday, December 20 report. The firm has “Buy” rating given on Monday, December 4 by KeyBanc Capital Markets. Mizuho maintained the shares of MD in report on Friday, February 9 with “Hold” rating. As per Monday, May 7, the company rating was maintained by Credit Suisse. The stock of MEDNAX, Inc. (NYSE:MD) has “Hold” rating given on Wednesday, January 24 by Mizuho. The rating was maintained by Robert W. Baird on Thursday, February 8 with “Hold”. SunTrust maintained the shares of MD in report on Thursday, February 8 with “Hold” rating. The firm earned “Market Perform” rating on Monday, February 12 by BMO Capital Markets.

MEDNAX, Inc. (NYSE:MD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.